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doi:10.1016/j.ejvs.2010.11.026Abstract Objectives: Objective of this study was to review the results of urgent carotid endar-
terectomy (CEA) performed in patients with recent (<24 h) or crescendo (at least 2 episodes in
24 h) transient ischaemic attack (TIA) or with acute stroke in a single centre experience.
Materials andmethods: FromJanuary 2000 toDecember2008, 75patients underwenturgentCEA
for severe internal carotid artery stenosis and recent/crescendo TIA (51 patients, TIA group) or
acute stroke (24 patients, stroke group). In patients with acute stroke the intervention was
proposed on the basis of clinical and instrumental features (patient conscious, patency ofmiddle
cerebral artery, no lesions or limited brain infarction at CT scan) according to neurologists’
suggestion. Data from all the interventions were prospectively collected in a dedicated data-
base, which includedmain pre-, intra- and postoperative parameters. Independent neurological
assessment with National Institute of Health Stroke Scale (NIHSS) score calculation was per-
formed before the operation and within the 30th postoperative day.
Early (<30days) resultswereevaluated in terms ofmortality,modifications inNIHSS values and
stroke and death rates. The surveillance program consisted of clinical and ultrasonographic
examinations at 1, 6 and 12months and yearly thereafter. Follow-up results (survival, occurrence
of ipsilateral stroke in TIA group, recurrence of stroke in stroke group) were analysed by
KaplaneMeier curves.
Results: Among patients presenting with TIA, 28 had crescendo TIAs and 23 had a recent TIA; In
stroke group, two patients had a stroke in evolution, eight patients had a recent major non-
disabling stroke and 14 patients had a recent minor stroke.
Preoperative mean value of NIHSS score in stroke group was 4.7 (SD 3.2).education questions on this paper, please go to www.vasculareducation.com and click on ‘CME’.
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352 W. Dorigo et al.There were 2 perioperative (<30 days) deaths, both in stroke group, in one case due to acute
respiratory failure and to fatal stroke in the other one (preoperative NIHSS value 9, postoperative
17), with a cumulative 30-day mortality rate of 2.7%, significantly higher in stroke group (8.3%)
than in TIA group (no death, pZ 0.03). No postoperative cerebral haemorrhage occurred.
In TIA group one postoperative major stroke occurred, with a 30-day stroke and death rate of
1.9%.
In surviving patients of stroke group NIHSS value improved in 13 cases, with a mean improve-
ment of 2 points (SD 0.9); in 8 cases the value remained unchanged, while in the remaining case
it increased from 2 to 4. Mean postoperative NIHSS score in stroke group was 3.9 (SD 3.7), signif-
icantly reduced in comparison with preoperative value (p < 0.001).
Mean duration of follow-up was 34 months (SD 28.1). No ipsilateral stroke in patients of TIA
group occurred; in stroke group a recurrent fatal stroke at 1 postoperative month was recorded.
Estimated 48-month stroke-free survival rate TIA group was 95% and 79% in stroke group
(pZ 0.02).
Conclusions: UrgentCEA inpatientswith recent/crescendoTIAprovided inour experienceexcel-
lent results, with low rates of perioperative and late stroke. In selected patients with acute
stroke early surgery seems to provide acceptable results.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Carotid endarterectomy (CEA) is a well-accepted method
for stroke prevention both in patients with moderate or
severe symptomatic carotid artery stenosis and in patients
with severe asymptomatic stenoses.1e3 By contrast, there is
no evidence from randomised trials to support the use of
emergent or urgent CEA in patients presenting with
unstable neurological status. Recent systematic reviews
have demonstrated increased perioperative risk with the
use of early CEA in patients with recent/crescendo tran-
sient ischaemic attacks (TIAs) and, to a greater extent, in
patients with stroke in evolution or acute fixed stroke.4,5
From our group,6 a previous study on early CEA in
patients with recent/crescendo TIA reported that although
satisfactory perioperative and long-term results may be
obtained, outcome in this urgent subgroup of patients was
slightly worse than in symptomatic patients with a stable
neurological status.
The aim of this study was to retrospectively update our
results in this subgroup of patients, including in the analysis
also patients with stroke in evolution and recent major non-
disabling stroke.
Materials and Methods
From January 2000 to December 2008, 3335 consecutive
CEAs in 2797 patients were performed at the University of
Florence. Data concerning these interventions were
prospectively collected in a dedicated database containing
150 fields, including anatomical, clinical, diagnostic and
technical variables. This database also contains periope-
rative (<30 days) results in terms of mortality and neuro-
logical morbidity, and all relevant clinical and diagnostic
data collected during follow-up. A post hoc analysis of this
database was performed and 75 urgent interventions
carried out in 75 patients with severe internal carotid
artery stenosis; and acute neurological event were identi-
fied: in 51 cases, the intervention was performed for
recent/crescendo TIA (TIA group), while, in the remainingpatients, the intervention was performed in patients with
stroke in evolution or recent major non-disabling or minor
stroke (stroke group).
Recent TIA was defined as a single episode of TIA, which
occurred within 24 h, while crescendo TIAs were defined as
two or more episodes within 24 h, with complete recovery
after each episode. Stroke in evolution was defined the
progression of a neurological deficit that had occurred over
at least 24 h, and recent stroke was defined as a fixed
neurological deficit occurring within the past 5 days. Minor
stroke was defined as any neurological event lasting more
than 24 h with recovery in several days without residual
functional impairment. Major non-disabling stroke was
defined as any neurological event lasting more than 24 h
with minimal residual neurologic deficit.
All the patients underwent preoperative duplex scanning
of extracranial vessels and angio-computed tomography
(CT) scan for the evaluation of cerebral parenchyma and
supra-aortic vessels. The degree of stenosis was deter-
mined by means of the North American Symptomatic
Carotid Endarterectomy Trial (NASCET) method.1 The
status of the vertebral arteries and intracranial vessels was
also examined during the preoperative assessment with
angio-CT scan. All the patients were preoperatively evalu-
ated by a consultant neurologist using the National Institute
of Health Stroke Scale (NIHSS) score assessment. In patients
with neurological deficit, the presence of impaired
consciousness, of fluctuating symptoms without complete
recovery between different episodes, of severe neurolo-
gical impairment (major disabling stroke), of middle cere-
bral artery occlusion, of ischaemic lesions larger than 1 cm
at CT scan and of a NIHSS score higher than 15 were
considered as contraindication for surgical intervention.
Patients not selected for surgery were admitted to a stroke
unit and then medically managed.
Patients’ characteristics were analysed in terms of
demographic data, common risk factors for atherosclerosis
and co-morbidities. Risk factors and co-morbidities included
arterial hypertension (defined as blood pressure greater than
130/85 mmHg or the need for anti-hypertensive medica-
tions), diabetes, defined as the need for specific drugs to
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triglycerides and cholesterol values > 200 mg/dl1), coro-
nary artery disease (history of myocardial infarction, angina
and previous coronary revascularisation) and peripheral
arterial disease (ankle/brachial index < 0.9).
Intra-operative data included type of anaesthesia,
cerebral monitoring and protection and technique of
carotid reconstruction. The choice of anaesthetic method
was at the discretion of the operating surgeon and ana-
esthesiologist. Patients undergoing CEA under general
anaesthesia had cerebral monitoring with somatosensory
evoked potentials (SEPs) and selective shunt insertion on
the basis of SEP abnormalities.7 With local anaesthesia or
our previously described Cooperative Patient General
Anaesthesia (CoPaGeA)8 technique, a carotid shunt was
inserted on the basis of clinical neurologic monitoring
during carotid clamping. At the end of the intervention
routine, completion angiography was performed.
Demographics, risk factors, co-morbidities, anatomical
indications for surgery and intra-operative technical
features were analysed and compared in both groups with
the c2 test and Fisher’s exact test, when necessary.
Neurological status was assessed daily in the immediate
postoperative period. Any postoperative death was recor-
ded; also, postoperative acute myocardial infarction (MI)
rate was assessed: the criteria for the diagnosis of MI were
the presence of cardiac enzymes’ elevations associated
with electrocardiographic and echocardiographic signs of
infarction. Cardiac enzymes were routinely checked on the
first postoperative day. After discharge, a 1-month follow-
up neurological evaluation was performed and new neuro-
logical events were assessed and defined and NIHSS values
were calculated.
Perioperative results were evaluated in terms of
mortality and 30-day stroke and death rate in the TIA group
and of mortality and NIHSS values’ modifications in the
stroke group; pre- and post-operative NIHSS values in the
stroke group were compared with the t-test for paired
variables. Univariate analysis for 30-day stroke and death
rate in the TIA group was performed. The analysis included
the following risk factors: sex, age greater than 79 years,
coronary artery disease, peripheral arterial disease, arte-
rial hypertension, diabetes, presence of contralateral
carotid occlusion, type of anaesthesia and cerebral moni-
toring, shunt insertion, type of arterial reconstruction,
characteristics of the TIA (recent or crescendo) and inter-
ventions performed within or beyond 24 h from the onset of
symptoms. Multivariate analysis (stepwise logistic regres-
sion analysis) for the same outcome with the inclusion of
the factors noted to be significant at univariate analysis was
performed. In the stroke group, univariate analysis for
improvement in NIHSS values at 30 days was performed.
The analysis included the following risk factors: sex, age
greater than 79 years, coronary artery disease, peripheral
arterial disease, arterial hypertension, diabetes, presence
of contralateral carotid occlusion, type of anaesthesia and
cerebral monitoring, shunt insertion, type of arterial
reconstruction, stroke characteristics (in evolution, major
or minor), preoperative NIHSS score higher or lower than 5
and interventions performed within or beyond 48 h from
the onset of symptoms. Multivariate analysis (stepwise
logistic regression analysis) for the same outcome with theinclusion of the factors noted to be significant at univariate
analysis was performed. Statistical significance was defined
as a p value less than 0.05.
Follow-up was performed at 1, 6, 12 months and yearly
thereafter, by clinical exam and duplex scan. All studies
were performed using an Acuson Sequoia 512 Ultrasound
System (Acuson Corporation, Mountain View, CA, USA).
Patients who did not complete follow-up examinations
had a telephone interview. During the telephone inter-
view, the following outcomes were assessed: patient’s
survival and cause of death, if known; and neurological
events and their time of appearance. Additional data
regarding long-term survival and major cardiovascular
events were obtained from the Regional Health Care
database.
Follow-up data were analysed by life-table analysis
(KaplaneMeier test) in terms of death, ipsilateral stroke in
TIA patients and recurrence of stroke in stroke patients.
Stroke-free survival rates in the TIA group and recurrence-
free survival rates in the stroke group were assessed.
Statistical analysis was performed by means of Statistical
Package for Social Sciences (SPSS) 15.0 for Windows (SPSS
Inc., Chicago, IL, USA).
Results
Demographic data, risk factors, co-morbidities and
anatomical status
There were not significant differences between the two
groups of patients in terms of demographic data, risk
factors and co-morbidities, except for a higher percentage
of octogenarians in the TIA group (Table 1). There were no
differences in terms of degree of carotid stenosis at the
operated side, of status of the contralateral internal
carotid artery and of type of intervention (primary or
secondary, Table 2).
Clinical details
Among patients presenting with TIA, 28 had crescendo TIAs
and 23 had a recent TIA. In 40 cases, only one neurological
symptom was present (contralateral upper extremity
weakness in 14 cases, contralateral hemiplegia in 12 cases,
contralateral lower extremity weakness in two cases,
amaurosis fugax in eight cases, disturbance of language in
three cases and central facial nerve paralysis in the
remaining case). In 11 cases, two of the above-mentioned
symptoms were present. Mean time interval between the
onset of symptoms and the intervention was 22.6 h (SD
13.7).
In the stroke group, two patients had a stroke in evolu-
tion, eight patients had a recent major non-disabling stroke
and 14 patients had a recent minor stroke. In 14 cases, only
one neurological symptom was present (contralateral
hemiplegia in six cases, contralateral upper limb paralysis
in five cases, contralateral lower limb paralysis in one case
and disturbance of language in three cases). In eight cases,
two of above-mentioned symptoms were present, while the
remaining two patients had three associated neurological
symptoms. Mean preoperative NIHSS score was 4.7 (SD 3.2).
Table 1 Patients’ demographic data, risk factors and co-morbidities.
TIA group (pts. 51) Stroke group (pts. 24) p
Female sex 9 (17.5%) 9 (37.5%) 0.06
Median age (years) 73.5 71.3 0.4
Age > 79 yrs. 10 (25%) e 0.01
Hypercholesterolemia 11 (21.5%) 6 (25%) 0.7
Hypertrigliceridemia 7 (13.5%) 4 (17%) 0.7
Diabetes mellitus 8 (15.5%) 7 (29%) 0.7
Arterial hypertension 26 (51%) 16 (66%) 0.2
Coronary artery disease 7 (13.5%) 3 (12.5%) 0.8
Peripheral artery disease 7 (13.5%) 6 (25%) 0.2
Smoker or past smoker 29 (57%) 19 (79%) 0.07
354 W. Dorigo et al.The mean time interval between the onset of symptoms
and the intervention was 52.5 h (SD 28.7).
Intra-operative details
Local anaesthesia or CoPaGeA with clinical monitoring were
used in 13 interventions in the TIA group (25%) and in seven
cases in the stroke group (29%; p Z 0.7). Shunt insertion
rates were similar between the two groups (33% TIA group
and 41% stroke group, p Z 0.4), with no differences in the
type of anaesthesia. In the TIA group, the shunt insertion
rate was 23% in patients undergoing local anaesthesia or
CoPaGeA and 37% in patients undergoing general ana-
esthesia (p Z 0.3); the corresponding values in the stroke
group were 28% and 41%, respectively (p Z 0.4). For arte-
rial reconstruction, a wide use of patch closure was noted
in both groups (84% in the TIA group and 83% in the stroke
group, p Z 0.3); the remaining patients had primary
closure.
Early results
Two perioperative deaths occurred, both in the stroke
group, in one case in a patient operated on for minor stroke
who died in first postoperative day of an acute respiratory
failure, and in the other case due to a fatal stroke
(preoperative NIHSS score 9, postoperative 17) in a patient
operated on for a tight carotid stenosis with intra-operative
finding of fresh thrombosis at the carotid bifurcation.
The cumulative 30-day mortality rate was 2.7%, signifi-
cantly higher in the stroke group (8.3%) than in the TIA
group (no death, p Z 0.03). No postoperative cerebral
haemorrhage or MI occurred.
In the TIA group, one perioperative major stroke
occurred in a patient with crescendo TIAs operated on forTable 2 Anatomical features.
TIA group (Pts. 51)
Degree of stenosis
60e80% 10 (19.5%)
>80% 37 (72.5%)
Near-occlusion 3 (6%)
Thrombosis 1 (2%)
Contralateral occlusion 3 (6%)left internal carotid artery near occlusion. The intervention
was performed under local anaesthesia with shunt insertion
due to the occurrence of a neurological deficit after 11 min
of carotid clamping, and complete recovery after shunting.
Patch closure was performed, and intra-operative comple-
tion angiography demonstrated patency of the operated
internal carotid artery and intracranial vessels. On first
postoperative day, the patient developed severe aphasia
(NIHSS 4) despite the patency of extra and intracranial
internal carotid artery assessed by angio-CT scan. At
discharge on the 10th postoperative day, the patient’s
clinical status was unchanged, and a new CT scan showed
the presence of limited, left-cortical brain infarction.
Cumulative 30-day stroke and death rate in TIA group
was 1.9%.
At univariate analysis for 30-day stroke and death rate in
TIA group, none of the examined factors were found to be
significant.
In the stroke group, the mean postoperative NIHSS score
was 3.9 (SD 3.7), significantly reduced in comparison with
preoperative values (p < 0.001; 95% confidence interval (CI)
0.1e1.7). In surviving patients in the stroke group, NIHSS
value improved in 13 cases, with a mean improvement of 2
points (SD0.9); ineightcases, thevalue remainedunchanged,
while in the remaining case, it declined from 2 to 4.
At univariate analysis for factors affecting NIHSS score
improvement at 30 days, none of the examined factors
were found to significantly affect this outcome (Table 3).
Follow-up results
The mean duration of follow-up was 34 months (SD 28.1); 71
patients (94.5%) had their follow-up completed. During
follow-up, five deaths occurred, three in the stroke group
and two in the TIA group. The causes of deaths in the strokeStroke group (Pts. 24) p
6 (25%) 0.3
12 (50%) 0.07
2 (8%) 0.5
4 (16.5%) 0.07
e 0.2
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two cases; in the TIA group, one patient died of a bladder
cancer and the other patient from a fatal cerebral
haemorrhage.
In the TIA group, neither ipsilateral nor contralateral
stroke was recorded. One patient had a new ipsilateral TIA
at 9 months, and significant restenosis of the operated
internal carotid artery was found and re-intervention was
planned, but the patient suffered from a fatal cerebral
haemorrhage prior to the scheduled procedure. Another
patient had a TIA from a mild-to-moderate stenosis of the
contralateral internal carotid artery at 20 months, and
underwent elective contralateral CEA.
In the stroke group, as previously noted, one patient
suffered from a fatal recurrent ipsilateral stroke at 1 month.
Cumulative estimated stroke-free survival rate at 48
months was 89.7%; the corresponding figures in the TIA and
stroke groups were 95.1% (standard error (SE) 0.03) and
79.2% (SE 0.08), respectively (p Z 0.02; log rank 5.1;
Fig. 1).Discussion
The first experiences in the treatment of ‘acute’ carotid
artery stenosis were described in the early 1960s and were
characterised by poor results, mainly due to postoperative
intracranial haemorrhage.9e11 As a consequence, in the
following 20 years, the avoidance of urgent CEA was
commonly accepted worldwide, and the intervention was
generally delayed up to 6 weeks after the clinical event.12
In recent years, however, significant improvements in
medical, surgical and anaesthesiological techniques andTable 3 Univariate analysis for NIHSS score improvement at 30
Risk factor
Female gender
Male gender
CAD
No CAD
PAD
No PAD
Arterial hypertension
No arterial hypertension
Diabetes
No diabetes
Preop. NIHSS < 5
Preop. NIHSS > 5
Symptoms’ onset < 48 h
Symtpoms’onset > 48 h
Stroke in evolution
Minor stroke
Major stroke
Local or CoPaGeA anaesthesia
General anaesthesia
Shunt insertion
No shunt insertion
Patch closure
Primary closurethe creation of territorial care networks for the treatment
of acute stroke has raised interest in the surgical treatment
of patients with unstable neurological symptoms.
In this study, we have analysed our experience in the
treatment of acute carotid artery stenosis, both in patients
with recent/crescendo TIAs and in patients with acute
stroke.
In the presence of recent or crescendo TIA, the role of
surgical intervention has already been described by several
studies. TIA represents a significant warning sign for
further, severe neurological events, with a risk of stroke of
5% in the first 48 h and 10% within 3 months.13 In patients
with severe or moderate carotid stenosis in the affected
hemisphere, the risk increases to 6% in the first 48 h and to
20% within 3 months,14 and becomes even higher in the
presence of crescendo TIAs.
On the basis of these data, the indication for urgent CEA
in patients with recent/crescendo TIAs seems compelling
considering that in most patients the ischaemic episode is
caused by a high-grade unstable stenosis, with morphologic
features of high risk for intracranial embolisation. These
were our criteria of the feasibility for surgical intervention,
similar to those adopted in many clinical studies,15e17
which report good results in this selected subgroup of
patients at high risk for early recurrent neurological events.
Our results in the TIA group were good, with a satisfac-
tory 30-day stroke and death rate of 1.9% and only one
postoperative stroke that occurred in a patient operated on
for internal carotid artery near occlusion. The role of
surgery in stroke prevention in patients with this pattern of
carotid disease is still controversial: while the NASCET
trial18 reported a significant advantage for surgical inter-
vention in these patients, a meta-analysis of pooled dataday in stroke group.
NIHSS improvement p
5/9 (55%)
9/15 (60%) 0.8
2/3 (66%)
12/21 (57%) 0.7
5/6 (83%)
9/18 (50%) 0.1
10/16 (62%)
4/8 (50%) 0.5
6/7(85%)
8/17 (47%) 0.08
7/15 (46%)
7/9 (77%) 0.1
6/10 (60%)
8/14 (53%) 0.8
2/2 (100%)
9/14 (65%)
3/8 (39%) 0.07
4/7 (57%)
10/17 (58%) 0.9
4/10 (40%)
10/14 (71%) 0.1
13/22 (59%)
1/2 (50%) 0.8
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Figure 1 Estimated stroke-free survival rate at 48 months in
TIA group and stroke group with number of patients at risk.
356 W. Dorigo et al.from randomised trials in symptomatic patients1 demon-
strated that the risk of stroke for medically treated
patients with near occlusion was lower than in patients
with severe stenosis, and the analysis of the long-term
effect of surgery in this group showed no significant benefit.
In our experience, we usually operate on patients with near
occlusion only in the presence of neurological symptoms;
however, the lack of data, particularly concerning the role
of CEA in patients with near occlusion and acute neuro-
logical events, makes any recommendation difficult.
Recent studies have reported that the stroke and death
rate in patients with crescendo TIA seems to be higher than
in patients operated on for a single, recent episode of TIA4;
also, in our series, the only postoperative stroke in the TIA
group occurred in a patient with crescendo TIA; however,
the limited number of events makes any further evaluation
unreliable.
As expected, our results in stroke patients were poorer
than those obtained in TIA patients, with a mortality rate of
8.3%, confirming the increased perioperative risk in this
subgroup of patients already described in other studies and
reviews.4,5 However we found a significant and encouragingimprovement in postoperative NIHSS score in more than 50%
of our surviving population, and only in one case was there
a slight impairment. One must consider that some improve-
ments in neurological status, particularly in patients with
minor ormajor non-disabling stroke, canbeexpected inmany
patients, and the absence of a control group (patients medi-
cally treated) in our series could make these results less
significant. Moreover, conclusionsmay have been affected by
the relatively small number of patients with stroke in evolu-
tion in strokepopulation,whilemostpatients in this grouphad
recent fixed neurological deficit. The risk of CEA in patients
with stroke in evolution in contemporary series has been
reported to be significant, with a threefold higher operative
risk in comparisonwith patients operated on for recent stable
stroke5; however, inour series, the twopatientswith stroke in
evolution had a favourable outcome, significantly improving
their NIHSS score values in the postoperative period.
There was no postoperative intracranial haemorrhage,
possibly explained by the careful preoperative diagnostic
assessment of patients and particularly by the evaluation of
the status of cerebral parenchyma, with the exclusion from
surgery of patients with large (>1 cm) new ischaemic
areas.19,20
We analysed also long-term results, and we are not
aware of a previous study describing the fate of acute
patients during follow-up. We found a significant difference
between the TIA and stroke groups in terms of long-term
survival, both related to the higher perioperative mortality
in the stroke group, suggesting these patients to have
a more severe systemic disease. Follow-up results in terms
of neurological outcomes were satisfactory, with low rates
of new events in both groups, confirming the long-term
effectiveness of CEA also in these subgroups of patients.
A crucial point in the management of unstable neuro-
logical patients is the strict collaboration with the neuro-
logist who should be, in our opinion, the team leader in the
decision-making process. This was also our strategy, and it
was supported by an effective network between the local
health-care system and our hospital. This is further
demonstrated by the reduced delay between symptom
onset and surgical intervention, ranging from 22 h in the TIA
group to 52 h in the stroke group, different from what is
reported in contemporary series, where unacceptable
delays in diagnosis and intervention are described in most
patients.21
This study has several limitations: it is a non-rando-
mised, retrospective study with a limited number of cases
and of events, and a relative heterogeneity of the study
population, particularly in stroke patients. However, due to
the paucity of data on this issue in the literature, our study
may add to the management of these complex patients.Conclusions
Urgent CEA in patients with recent/crescendo TIA provided,
in our experience, excellent results, with low rates of
perioperative and late stroke. In selected patients with
acute stroke, early surgery seems to provide acceptable
results.
Careful patients’ selection, with close collaboration of
different specialists (neurologists, neuroradiologists and
Urgent Carotid Endarterectomy in Patients with Transient Ischaemic Attacks or Acute Stroke 357vascular surgeons in a multidisciplinary unit), is critical to
improve the results of surgical intervention and to reduce the
incidence and the severity of early and late complications.
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